regorafenib monohydrate
A monohydrate salt of Regorafenib, a multikinase inhibitor used in the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumors. Shows anti-angiogenic activity due to its dual targeted VEGFR2-TIE2 tyrosine kinase inhibition.Reference standards of Regorafenib Monohydrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Regorafenib Monohydrate - API Standards
[catalogue_number] => PA 18 35000
[category_ids] => ,80,71,76,75,78,70,82,89,
[chemical_name] =>
[weight] => 500.83
[form] => C21H17ClF4N4O4
[cas] => 1019206-88-2
[pslug] => 1019206-88-2-regorafenib-monohydrate-api-standards-pa1835000
[latest_product] => 0
[linkproducts] => 1
[offers_id] => 1
[offers_name] => Spring Season Offer
[offers_status] => 1
[offers_start_date] => 2024-03-27
[offers_end_date] => 2024-03-31
[pageview] => 2
[offers_slug] => spring-season-offer
[offers_product_id] => 4077
[offers_product_code] => PA 18 35000
[offers_master_id] => 1
[offer_percentage] => 20% OFF
[offers_product_main_cat] => Pharmaceutical Reference Standards
)
Regorafenib Monohydrate - API Standards
Catalogue No.:PA 18 35000
Molecular Formula : C21H17ClF4N4O4
Molecular Weight : 500.83